The latest update is out from Mayne Pharma Group ( (AU:MYX) ).
State Street Corporation and its subsidiaries have ceased to be substantial holders in Mayne Pharma Group as of April 7, 2025. This change in substantial holding could impact the company’s shareholder dynamics and influence its market positioning, as State Street’s involvement in the company has altered.
More about Mayne Pharma Group
Mayne Pharma Group is a pharmaceutical company that focuses on the development and manufacturing of branded and generic pharmaceuticals. It operates in the healthcare industry, providing a range of products that cater to various medical needs.
YTD Price Performance: 47.40%
Average Trading Volume: 2,183
Technical Sentiment Signal: Sell
Current Market Cap: $339.5M
For detailed information about MYX stock, go to TipRanks’ Stock Analysis page.